Tag: upstream manufacturing.

Policymakers must understand the relevance of China in U.S. drug supply chains, with a focus on diversifying supplies, reducing dependence on Chinese chemicals, and addressing drug shortages, especially in generics. China has a significant stake in drug inputs, but not as much in active pharmaceutical ingredients.